Lymphomatoid Granulomatosis clinical trials
The registry lists 5 studies for Lymphomatoid Granulomatosis across 6 countries. 1 are recruiting or about to start. 1 of them are mainly about Lymphomatoid Granulomatosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13.
Get an email when these change. Save the Lymphomatoid Granulomatosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Cancer Institute (NCI) (3) · Jichi Medical University (1) · Xencor, Inc. (1)
What is being tested here
Drugs under test in Lymphomatoid Granulomatosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Varlilumab | 0 | 0 | 1 |
| Interferons | 0 | 0 | 1 |
| Rituximab | 0 | 0 | 1 |
| Epoetin Alfa | 0 | 0 | 1 |
| Plamotamab | 0 | 0 | 1 |
Who these studies take
Of the 1 Lymphomatoid Granulomatosis studies recruiting now, 1 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 1 (100%) | 1 (100%) |
| 30 | 1 (100%) | 1 (100%) |
| 40 | 1 (100%) | 1 (100%) |
| 50 | 1 (100%) | 1 (100%) |
| 65 | 1 (100%) | 1 (100%) |
| 75 | 1 (100%) | 1 (100%) |
| 85 | 1 (100%) | 1 (100%) |
Across all 5 studies, recruiting or not: 20% stop at 75 or younger and 0% at 65; 20% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 5 of 5. search them.
- Tissue Collection for Studies of Lymph CancerRecruitingNCT016768052 countries
- Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell LymphomasActive, not recruitingNCT03038672Phase 21 country
- Treatment and Natural History Study of Lymphomatoid GranulomatosisCompletedNCT00001379Phase 21 country
- Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic MalignanciesCompletedNCT02924402Phase 14 countries
- Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T LymphocytesStatus unknownNCT02134262Phase 1/21 country